Not Signed In -
Melanoma |
Melanoma cancer |
This article is a candidate for the Medicine Collaboration of the Week. Please visit that page to support or comment on the nomination. This article or section does not cite its references or sources. You can help Wikipedia by introducing appropriate citations. Melanoma is a malignant tumor of melanocytes. Melanocytes predominantly occur in the skin but can be found elsewhere, especially the eye. The vast majority of melanomas originate in the skin. Melanomas are the most lethal form o ...
Wikipedia - [full article]
Melanoma Clinical Trials
- Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00004153 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
- PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00004152 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003339 - Active, not recruiting
Stage IV Melanoma; recurrent intraocular melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00005633 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma
ClinicalTrials.gov Identifier: NCT00002973 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00016263 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00052988 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- Vaccine Therapy With Immune Adjuvant in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00085137 - Active, not recruiting
Recurrent Melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089193 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Temozolomide and Interferon alfa in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00027742 - Active, not recruiting
iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00003897 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Boron Neutron Capture Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00059800 - Active, not recruiting
Recurrent Melanoma; stage 0 melanoma; stage I melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
- Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00002781 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00081042 - Active, not recruiting
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
ClinicalTrials.gov Identifier: NCT00089063 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ...
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00288041 - Active, not recruiting
Intraocular Melanoma; Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00334776 - Active, not recruiting
Intraocular Melanoma; Melanoma (Skin)
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003552 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00238329 - Active, not recruiting
Intraocular Melanoma; Melanoma (Skin)
- Suberoylanilide Hydroxamic Acid in Treating Patients with Metastatic Or Unresectable Melanoma
ClinicalTrials.gov Identifier: NCT00121225 - Recruiting
Recurrent Melanoma; Stage IV Melanoma; recurrent intraocular melanoma; iris melanoma; extraocular extension melanoma; ...
- FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
intraocular melanoma; Melanoma
- Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003646 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003346 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00007969 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002817 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00004184 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00104845 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00037037 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
ClinicalTrials.gov Identifier: NCT00070343 - Active, not recruiting
Stage IV Melanoma; stage III melanoma
- Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
ClinicalTrials.gov Identifier: NCT00049010 - Active, not recruiting
stage I melanoma; stage II melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00053391 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00066196 - Active, not recruiting
Melanoma; Malignant Metastatic Melanoma
- Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00004141 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00045357 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Tipifarnib in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00060125 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00107159 - Active, not recruiting
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003222 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy with Or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00118313 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma
- Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002845 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00017355 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Surgery in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002860 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- CCI-779 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00022464 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00087373 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00005815 - Active, not recruiting
intraocular melanoma; Melanoma
- Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00072345 - Active, not recruiting
intraocular melanoma; Melanoma
- Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00082875 - Active, not recruiting
stage III melanoma; Stage IV Melanoma
- Peptide Vaccine, Montanide ISA 51, and CpG 7909 in Treating Patients With Resected Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00085189 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ...
- Multiepitope Peptide Vaccination in Melanoma
ClinicalTrials.gov Identifier: NCT00153569 - Active, not recruiting
Metastatic Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00022568 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Everolimus in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00098553 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
ClinicalTrials.gov Identifier: NCT00450593 - Recruiting
Hereditary Melanoma 1 and 2 (cdkn2, cdk4); Melanoma (Skin)
- Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003747 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00003556 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Gene Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005943 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00071981 - Recruiting
Stage IV Melanoma; Recurrent Melanoma
- Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00006035 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; Quality of Life
- Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
ClinicalTrials.gov Identifier: NCT00086866 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003224 - Active, not recruiting
Stage IV Melanoma; stage II melanoma; stage III melanoma; Recurrent Melanoma
- Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
ClinicalTrials.gov Identifier: NCT00004196 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
ClinicalTrials.gov Identifier: NCT00017121 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; lung metastases
- Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
Malignant Melanoma
- Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00116597 - Active, not recruiting
Melanoma
- Vaccine Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00033228 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer Involving the Central Nervous System
ClinicalTrials.gov Identifier: NCT00068666 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; brain metastases
- Novel Adjuvants for Peptide-Based Melanoma Vaccines
ClinicalTrials.gov Identifier: NCT00028431 - Recruiting
Melanoma
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003647 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00045149 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- High-Dose or Low-Dose Interferon alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00002763 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00128583 - Active, not recruiting
stage III melanoma
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00004025 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Study of Individuals and Families at High Risk for Melanoma
ClinicalTrials.gov Identifier: NCT00045240 - Recruiting
Hereditary Melanoma 1 and 2 (cdkn2, cdk4); Melanoma (Skin)
- Lenalidomide in Treating Patients With Stage IV Eye Melanoma
ClinicalTrials.gov Identifier: NCT00112606 - Recruiting
ciliary body and choroid melanoma, medium/large size; extraocular extension melanoma; iris melanoma; recurrent intraocular melanoma
- Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
ClinicalTrials.gov Identifier: NCT00040352 - Recruiting
Melanoma
- Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation
ClinicalTrials.gov Identifier: NCT00471133 - Recruiting
Melanoma (Skin); Intraocular Melanoma
- Temozolomide or Dacarbazine in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00101218 - Active, not recruiting
Recurrent Melanoma; Stage IV Melanoma
- Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00313508 - Recruiting
Intraocular Melanoma; Melanoma (Skin)
- M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00477906 - Recruiting
Melanoma
- CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
ClinicalTrials.gov Identifier: NCT00090896 - Active, not recruiting
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00039325 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00010309 - Active, not recruiting
Stage IV Melanoma; stage II melanoma; stage III melanoma
- Phase I Safety Study Of The Combination Of Lenalidomide And DTIC (Dacarbazine) In Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
ClinicalTrials.gov Identifier: NCT00179608 - Active, not recruiting
Malignant Melanoma
- E7070 in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00014625 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vinorelbine in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003828 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interferon alfa Plus Radiation Therapy in Treating Patients With Stage III or Recurrent Melanoma That Has Been Removed by Surgery
ClinicalTrials.gov Identifier: NCT00005615 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00064168 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00091572 - Active, not recruiting
Melanoma
- Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00255762 - Active, not recruiting
Recurrent Melanoma; Stage IV Melanoma
- Combination Chemotherapy, Interferon alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002669 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00016055 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00243061 - Recruiting
Intraocular Melanoma; Melanoma
- A Trial To Evaluate Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00107718 - Active, not recruiting
Melanoma; Metastases
- Treatment for Subjects with Unresectable Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00110994 - Active, not recruiting
Malignant Melanoma; Cancer
- Vaccine Therapy for Patients with Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00052156 - Active, not recruiting
Malignant Melanoma
Resources
- "Hidden" Melanomas (American Academy of Dermatology)
- ABCDs of Melanoma Detection (American Academy of Dermatology)
email this page
print this page
bookmark this page
feedback on this page
